Accsys Technologies Share Discussion Threads

[ba5hir is back] 11/12/2007 15:17

Dead cat bounce.

[goosegreen] 11/12/2007 09:11

Good news today - a la drop!

120 day option

end of year is 30 March 2009

end of option is about 11 April 2009

So maybe in next years results.

[ba5hir is back] 07/12/2007 14:56

Downtrend broken. Next stop 2.75p.

[ba5hir is back] 07/12/2007 14:28

Just as I predicted it will drop big time soon...

[ba5hir is back] 06/12/2007 11:02

New short term low exit is my advice!

[ba5hir is back] 06/12/2007 10:53

Hanging on a thread this could drop big style soon.

[damanko] 06/12/2007 10:37

I agree philjeans. Doing a "sum of the parts" in terms of M&C stakes in Medicsight and Accsys, I make the NAV not a lot more than 10pence. As you know STG/M&C has about 650 million shares in issue. About 96% belonging to the 3 main players, who - surprise, surprise - are directors of Accysy. Financial engineering, however you look at it. In any case I shall be rattling off a letter to the new chairman. May go to the EGM, if and when it is arranged, probably early next year.

FB - The letter I mention relates to shareholders in MacNiven & Cameron only, which holds 13.44% of Accsys Technologies. M&C is unlisted, and has survived under various names since the old EIS days in the 80's. There are a few of us left, stuck with the shares, and looking for a decent exit.

[philjeans] 06/12/2007 10:15

Yes Damanko; I had a letter too - thought I'd await the "meat" with prices etc next year before getting excited.

I think the offer will still be way below our original investment in STG.

[foreverbull] 06/12/2007 10:04

Damanko
Thanks for that shareholder info update.

I am struggling to understanding your Post 882.

What is this all about "Buy back" or "voluntary liquidation"?

I have not received any letter.

Could you give me some idea please

Thanks
FB

[damanko] 05/12/2007 18:54

Also, for anyone interested:

MacNiven & Cameron Equity Holdings Limited has recently written to shareholders, confirming that the chairman has died, however the company still intends to "Afford minority shareholders the opportunity of an exit.".

Either "By way of a voluntary winding up of the company or by a share buy back."

Shareholders will receive a letter "Within the next few weeks" regarding either notice of an EGM to put the company into voluntary liquidation, or details of the proposals for a share buy back.

Any (sensible) comments welcome.

damanko

[damanko] 05/12/2007 18:41

Apologies for interrupting your insightful & meaningful contributions, Ba5hir, which continue to enthral most on this thread. However, just a note to say that I've updated the header, in terms of major holdings, as well as director's interests. Here it is again:

The following shareholders held beneficial interests in the Ordinary shares
exceeding 3%:


MacNiven and Cameron Equity Holdings Limited 13.44%
Saad Investments Company Limited 8.61%
Oak Foundation USA Inc, and related parties 8.07%
Rajhi Holdings 6.07%
Celanese Chemicals Europe GmbH 5.46%
Rathbone Investment Management Limited 3.90%
UBS Wealth Management (UK) Limited 3.83%
Axa Framlington 3.50%



Directors


The directors of the company throughout the year were:


Willy Paterson-Brown
Stefan Allesch-Taylor
Gordon Campbell
Tim Paterson-Brown
Edward J Pratt resigned 26 June 2007
Glyn C Thomas



Directors' interests in the Ordinary shares of the Company are set out below:


Ordinary shares Options over Ordinary shares
31 March 2007 31 March 2006 31 March 2007 31 March 2006

Willy Paterson-Brown *20,000,000 *20,000,000 2,440,000 1,440,000
Stefan Allesch-Taylor *20,000,000 *20,000,000 - -
Gordon Campbell 48,172 48,172 - -
Tim Paterson-Brown *20,000,000 *20,000,000 - -
Edward J Pratt 720,618 618 1,720,000 1,440,000
Glyn C Thomas 480,618 618 1,230,000 960,000



Note * 20,000,000 Ordinary shares and 415,184 Deferred shares are
registered in the name of MacNiven and Cameron Equity Holdings Limited. Messrs
S Allesch-Taylor, W Paterson-Brown and Mr T Paterson-Brown have beneficial
interests in those shares as they are three of the discretionary beneficiaries
of a trust which owns the majority of the issued share capital of MacNiven and
Cameron Equity Holdings Limited. None of these persons can exercise, or
influence the exercise of, the voting rights of the Ordinary and Deferred shares
held by MacNiven and Cameron Equity Holdings Limited.



Directors' share options:
At Granted Exercised At 31
1 April 2006 during year during year March 2007
Willy Paterson-Brown
Vested at €0.46 720,000 - - 720,000
Unvested at €0.46 720,000 - - 720,000
Unvested at €2.59 - 1,000,000 - 1,000,000

Edward Pratt
Vested at €0.46 720,000 - 720,000 -
Unvested at €0.46 720,000 - - 720,000
Unvested at €2.59 - 1,000,000 - 1,000,000

Glyn Thomas
Vested at €0.46 480,000 - 480,000 -
Unvested at €0.46 480,000 - - 480,000
Unvested at €2.59 - 750,000 - 750,000



Options granted on 1 March 2005 at an exercise price of €0.46 per Ordinary share
vested 50% upon grant and 50% will vest upon the group achieving a cumulative €1
million in revenue from 1 April 2005. Once vested, these options may be
exercised until 30 March 2015.



Options granted on 28 March 2007 at an exercise price of €2.59 per Ordinary
share vest as to one third of the options granted upon achievement of each of
the following:

[ba5hir is back] 05/12/2007 10:30

Dump em they go weaker every day.

[ba5hir is back] 30/11/2007 14:23

Ready for another short term low....lol

[spudders] 27/11/2007 19:37

ba5hir = T*sser, I think many may agree

[ba5hir is back] 27/11/2007 10:57

Down again...lol

[ba5hir is back] 26/11/2007 10:57

Weak again thsi will get a very bad reality check soon....

[foreverbull] 23/11/2007 12:36

Ba5hir is back - 23 Nov'07 - 10:41 - 873 of 873

The market does not agree sell.


Agreed
We got your point.Please do not waste your time and energy trying to explain same point again and again.

[ba5hir is back] 23/11/2007 10:41

The market does not agree sell.

[hew] 22/11/2007 14:38

See today's Independent. Edited important bits only below. One day some newspaper will make an example of some poster who pastes the lot!


_______________________

Our view: Buy

... first-half loss was in line, most through listing on Euronext .... opens doors to high-class institutional investors.

Revenue ...... for the calendar year revenue is close to Euro22m.
..... deal with Diamond Wood China looks particularly juicy.

....no stock for the faint-hearted, and given the strong run ..... a chance that they will tread water until new contracts are made public. But new contracts are in the pipeline, and for higher-risk investors this looks well worth tucking away..

[ba5hir is back] 21/11/2007 15:22

Lead balloon lately. Overhyped stock.

[goosegreen] 21/11/2007 09:53

Extract from the Chairman's Statement from the Interim results for six months to Sept 30 2007

Introduction

The period covered by this report has seen excellent progress for your Company.
The world's first AccoyaTM production facility has been commissioned and we have
seen very strong interest amongst many potential licensees to utilise the
group's proprietary production technology. Recent Licensing activity has
boosted the Company significantly, resulting in considerable revenue which means
that the Directors are confident that results for the year will be in line with
their expectations.


This follows on from this extract from the Directors' Report for the year ended 31 March 2007

Taken from the Conclusion

Your Company is well positioned for the challenges in the year ahead. We have created a strong, solid base from which we are able to expand our business on a global scale. Over the past two years, we have moved from a technology development business to a full commercial operating business, with an order book that is testament to the quality of our product, a brand that is increasingly recognised as leading its field and an extremely promising new business pipeline.

2006-7 has been a landmark year for your Company. The prospects for 2007-8 are exciting. We expect to see significant revenue during the course of the year ahead and hope to be able to report a profit for the year.


Willy Paterson-Brown, Chairman & Chief Executive

28 June 2007


From the two statements above the directors hope to be in profit this year.

Taking stated sales and costs I would estimate that Accsys is now in break even position for the current year (ends 31 march 2008).

The announced income of euro17.5M and first half loss of euro5M taken with my guestimated second half costs of euro10-12M would leave a small profit of euro0.5-2.5M.

Any new revenue announcements will go towards an increased maiden profit.

I look forward to Accsys progressing as a company with increasing shareholder value.

This is just my opinion of course! As always dyor etc

Jon

[silverthread] 21/11/2007 07:32

INTERIM RESULTS FOR THE SIX MONTHS TO 30 SEPTEMBER 2007
ACCSYS TECHNOLOGIES PLC ('Accsys' or 'the Company')

Highlights
• Results for the 6 month period show revenue of €3.8 million (2006: €nil)
and a pre tax loss of €5.0 million (2006: loss of €3.5 million), broadly in
line with business plans.
• Current net cash position of €53 million with no existing debt
• Listing on Euronext Amsterdam, with the placing of 5 million new Ordinary
shares raising €18.5 million after expenses.
• Good progress in scaling up the production processes at the group's own
AccoyaTM production facility. Supplies of AccoyaTM now being distributed
across UK, Netherlands and Germany.
• Plans being drawn up to double AccoyaTM production capacity at our Arnhem
facility
• Development work proceeding on acetylated fibre board opportunities

Post period Highlights

• Strong progress with other potential Licensees, including an option with
Al Rajhi for 100,000 cubic metres in the GCC countries
• Appointment of Finlay Morrison as CEO
• Licensing Agency Agreement with Skanfore now fulfilled enabling €8 million
agency revenue previously received to be recognised through profit and loss
during the second half
• First License Agreement signed with Diamond Wood China for 500,000 cubic
metres nameplate annual capacity with €9.5 million revenue arising during
the second half

Willy Paterson-Brown commented: 'Accsys has seen excellent progress in the year
to date, with recent licensing activity significantly increasing revenue and the
worlds first Accoya production facility being commissioned. We are delighted to
welcome Finlay Morrison as CEO, and the Board looks forward to a strong second
half.'

[goosegreen] 20/11/2007 10:28

Good - he/she/it was filtered!

[asparks] 20/11/2007 09:44

bashir has gone. what a surprise